Moreover, tumor-derived cytokines, such as G-CSF and GM-CSF, activate downstream signaling pathways, particularly STAT3 and STAT5, which drive the expression of lipid transport receptors such as CD36 on MDSCs. This evidence concerns the gene STAT3 and neoplasm.